GlassScriptPhysician profile
Alexis Dominguez
NPI 1891939294
$3,381.61
in general payments reported to CMS, 2019-2025
21 companies · $459 in 2025
The $459 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $641 · 2020: $199 · 2021: $501 · 2022: $528 · 2023: $679 · 2024: $375 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,329 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,328.98 |
| Education | $183.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $805.16 | 2021-2025 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Abbvie INC. | $785.11 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Mayne Pharma Commercial LLC | $268.42 | 2023-2025 | |
| Astellas Pharma US INC | $246.57 | 2024-2025 | Veozah |
| Intuitive Surgical, INC. | $229.95 | 2019-2023 | Da Vinci Surgical System |
| Coopersurgical, INC. | $209.87 | 2019-2025 | Endosee, Paragard T 380a, Wallach Cryosurgical Equipment |
| Axonics, INC. | $157.26 | 2023 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $147.38 | 2019-2025 | |
| Biogen, INC. | $85.41 | 2025 | Zurzuvae |
| Ethicon US, LLC | $71.94 | 2019 | |
| Avion Pharmaceuticals | $61.77 | 2020-2021 | |
| Myovant Sciences INC. | $52.59 | 2022 | |
| Pfizer INC. | $48.31 | 2024 | |
| Millicent US INC | $48.08 | 2024-2025 | Femring, Intrarosa |
| Sumitomo Pharma America, INC. | $46.84 | 2023-2025 | Gemtesa, Myfembree |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $30.96 | 2019 | |
| Organon LLC | $26.36 | 2024 | |
| Roche Diagnostics Corporation | $21.16 | 2019 | |
| Avanos Medical | $16.83 | 2019 | |
| Merck Sharp & Dohme LLC | $14.19 | 2019 | |
| Channel Medsystems, INC. | $7.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Dominguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.